| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |